Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T ConsortiumLoretta J. Nastoupil, Frederick L. Locke, Armin Ghobadi et al.|Journal of Clinical Oncology|2020Cited by 782
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part oneAndreas Lundqvist, James Geib, Vincent van Hoef et al.|Journal for ImmunoTherapy of Cancer|2016Cited by 11